Results 271 to 280 of about 188,637 (301)

Neural circuits underlying a psychotherapeutic regimen for fear disorders

Nature, 2019
Jinhee Baek, Minsoo Kim, Jaeseung Jeong
exaly  

A basal-bolus insulin regimen integrated microneedle patch for intraday postprandial glucose control

Science Advances, 2020
Bo Zhi Chen, Yi Yun Xia, Xin Dong Guo
exaly  

dosage regimen

2009
openaire   +1 more source

Estimating drug-dosage regimens.

Lancet (London, England), 1970
D A, Mitchison, W, Fox
openaire   +3 more sources

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

Journal of Clinical Oncology, 2003
Lori J Goldstein, Larry Norton
exaly  

Dosage Regimens

2017
openaire   +1 more source

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

Journal of Clinical Oncology, 2005
Susan M O'brien, Michael Andreeff, Jorge Cortes   +2 more
exaly  

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

Lancet Haematology,the, 2016
Andrés José Maria Ferreri, Kate Cwynarski, Maurilio Ponzoni   +2 more
exaly  

Chemoimmunotherapy With a Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome–Negative Precursor B-Lineage Acute Lymphoblastic Leukemia

Journal of Clinical Oncology, 2010
Guillermo Garcia-Manero, Farhad Ravandi, Jorge Cortes   +2 more
exaly  

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

Lancet, The, 2005
Bart Jan Kullberg
exaly